Cost-effectiveness study of three antimalarial drug combinations in Tanzania
about
Impact of home-based management of malaria on health outcomes in Africa: a systematic review of the evidenceSafety and efficacy of methylene blue combined with artesunate or amodiaquine for uncomplicated falciparum malaria: a randomized controlled trial from Burkina FasoAn economic evaluation of home management of malaria in Uganda: an interactive Markov modelRapid testing for malaria in settings where microscopy is available and peripheral clinics where only presumptive treatment is available: a randomised controlled trial in Ghana.Inhibition of human immunodeficiency virus type-1 by cdk inhibitorsComparative field performance and adherence to test results of four malaria rapid diagnostic tests among febrile patients more than five years of age in Blantyre, MalawiCoverage, adherence and costs of intermittent preventive treatment of malaria in children employing different delivery strategies in Jasikan, GhanaCost-effectiveness of dihydroartemisinin-piperaquine compared with artemether-lumefantrine for treating uncomplicated malaria in children at a district hospital in Tanzania.Artemether-lumefantrine: an option for malaria.Performance of HRP-2 based rapid diagnostic test for malaria and its variation with age in an area of intense malaria transmission in southern Tanzania.Modeling the cost effectiveness of malaria control interventions in the highlands of western KenyaPharmacoeconomics and its implication on priority-setting for essential medicines in Tanzania: a systematic review.Rapid diagnostic tests compared with malaria microscopy for guiding outpatient treatment of febrile illness in Tanzania: randomised trial.Cost-effectiveness of three malaria treatment strategies in rural Tigray, Ethiopia where both Plasmodium falciparum and Plasmodium vivax co-dominateChallenges Associated with Scaling up Artemisinin Combination Therapy in Sub-Saharan Africa A Review ArticleMalaria diagnostic testing and treatment practices in three different Plasmodium falciparum transmission settings in Tanzania: before and after a government policy change.Overuse of artemisinin-combination therapy in Mto wa Mbu (river of mosquitoes), an area misinterpreted as high endemic for malaria.A cost-effectiveness analysis of artemether lumefantrine for treatment of uncomplicated malaria in Zambia.Cost-effectiveness of malaria diagnosis using rapid diagnostic tests compared to microscopy or clinical symptoms alone in Afghanistan.Randomized clinical trial of artemisinin versus non-artemisinin combination therapy for uncomplicated falciparum malaria in Madagascar.Priority setting for the implementation of artemisinin-based combination therapy policy in Tanzania: evaluation against the accountability for reasonableness frameworkFinancial implications of refugee malaria: the impact of pre-departure presumptive treatment with anti-malarial drugsThe impact of response to the results of diagnostic tests for malaria: cost-benefit analysis.Analyzing Thiol-Dependent Redox Networks in the Presence of Methylene Blue and Other Antimalarial Agents with RT-PCR-Supported in silico Modeling.Economic costs of fever to households in the middle belt of Ghana.Guidelines and mindlines: why do clinical staff over-diagnose malaria in Tanzania? A qualitative study.Malaria - an overview.Deployment of ACT antimalarials for treatment of malaria: challenges and opportunities.The content of African diets is adequate to achieve optimal efficacy with fixed-dose artemether-lumefantrine: a review of the evidence.Cost-effectiveness analysis of introducing RDTs for malaria diagnosis as compared to microscopy and presumptive diagnosis in central and peripheral public health facilities in Ghana.Diagnosis of malaria: challenges for clinicians in endemic and non-endemic regions.Recent advances in artemisinin production through heterologous expression.Malaria treatment and prophylaxis in endemic and nonendemic countries: evidence on strategies and their cost-effectiveness.Cost-effectiveness of artesunate for the treatment of severe malaria.Diagnosis of malaria in children's outpatient departments in Abuja, Nigeria.Point of care investigations in pediatric care to improve health care in rural areas.Synthesis, antimalarial activity, and intracellular targets of MEFAS, a new hybrid compound derived from mefloquine and artesunate.Market for Artemether-Lumefantrine to treat childhood malaria in a district of southern Mozambique.In areas of low transmission, is the presumptive treatment of febrile but bloodsmear-negative patients for malaria validated by the results of PCR-based testing?PfeIF4E and PfeIF4A colocalize and their double-stranded RNA inhibits Plasmodium falciparum proliferation.
P2860
Q28222513-45AF51CF-A18B-416E-9166-B6B59EAD5F3DQ28472182-5AABE31E-B45D-40D6-8F0C-FBEC905339AEQ28475337-707EB850-308D-4033-8B60-1DB6656879D0Q33708088-3F206B32-394E-4CC6-B1F6-45AB485EE493Q33780297-BF4E9006-9816-475C-A766-89ED4BD57FE7Q34047593-7F8EE409-8D8C-450B-862F-B49B88AD3716Q34071486-9B990AAA-D1E4-48F2-B0F8-719D39F29B8EQ34227179-99FB3381-98C8-44E4-A7BB-12B8E3D9A360Q34267667-462EB9F9-11C0-4230-A402-1EB9A3F10D25Q34283087-9F937C47-2B5A-4716-8122-D2F6EDC1B050Q34301503-5C1A1DCF-9A7B-441A-B52F-82A108C26895Q34422906-FC30F54F-6730-4D62-90E9-E757E9A39867Q34607042-3B48B103-A029-4ABE-BC82-F67CCD9FF908Q34610996-AD6A5758-9940-458E-AFE8-F66D530B270AQ34780397-56B9DC17-4802-487F-BE1B-3318666912A3Q34832467-F18D9B05-7939-4651-BF77-617DDC1F7122Q34873304-4D32B3B1-D4AD-49F6-9999-3FCE8605C06DQ35649120-53540E4C-D1F7-4C21-9FCD-4939FD6F6128Q35669442-1281C174-6A9C-4C50-8710-F4950D03636BQ35834329-8788E68A-8DAF-40E9-9D0A-6F63CEA9ED3AQ35951057-AA2A57CF-9817-45DC-8BF5-D9A4E694117EQ36145642-C0F02533-3205-4F63-AABD-31794F7CCD5EQ36405433-98983DB9-C7B4-468E-991B-B527A3369DB6Q36450015-87DD64C0-7DFD-435B-9200-8C6D79DB2A4FQ36553250-5632A0A3-3257-4C37-890B-86332A872788Q36570068-6C8D034B-38F3-49E6-994C-7536F3DD7A77Q36933774-47FA0E2E-DA6A-44FD-B59A-130F65741D88Q37018626-BA0B9F99-1B9E-4548-9E85-B7FA93924827Q37032498-8A410D8A-A36C-4CB1-B988-8C06162D5C49Q37225803-24ECFFAB-36E7-4F4B-8D1C-B6489441CB78Q37273671-DEADA5B3-2932-4805-AA2D-3633A83AD983Q37320297-C4E74710-E3F8-40C8-8482-7CF95EBF20C3Q37961911-6526CE41-28AB-4224-8A24-6ECA307DFCF5Q39192466-01A216C9-D8F9-4015-B420-FC6F58F5BFE2Q39308346-C5ABC12F-077A-436F-A5FF-BB540982C0C0Q39568887-A2B3C368-D7D3-4689-8134-896CB73D5664Q39949618-8F075C4E-40EC-46FF-A115-7901D17EB966Q40184152-CFA63F7E-AC92-41E6-BD4B-C9A96081D7A5Q40342877-CBFFB49F-7D73-4EBF-AA99-F0F25FB48B62Q41817107-950AF173-44A6-4CFE-9165-18C128105431
P2860
Cost-effectiveness study of three antimalarial drug combinations in Tanzania
description
2006 nî lūn-bûn
@nan
2006 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Cost-effectiveness study of three antimalarial drug combinations in Tanzania
@ast
Cost-effectiveness study of three antimalarial drug combinations in Tanzania
@en
Cost-effectiveness study of three antimalarial drug combinations in Tanzania
@nl
type
label
Cost-effectiveness study of three antimalarial drug combinations in Tanzania
@ast
Cost-effectiveness study of three antimalarial drug combinations in Tanzania
@en
Cost-effectiveness study of three antimalarial drug combinations in Tanzania
@nl
prefLabel
Cost-effectiveness study of three antimalarial drug combinations in Tanzania
@ast
Cost-effectiveness study of three antimalarial drug combinations in Tanzania
@en
Cost-effectiveness study of three antimalarial drug combinations in Tanzania
@nl
P2860
P1433
P1476
Cost-effectiveness study of three antimalarial drug combinations in Tanzania
@en
P2093
Michelle Kim
Theonest K Mutabingwa
P2860
P356
10.1371/JOURNAL.PMED.0030373
P407
P577
2006-10-01T00:00:00Z